With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in 20 years. Six years ago, in a townhouse in Santa Monica, Mario Danek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback